Exploring the mechanism of action of Qian Lie Xing Fang during the treatment of benign prostatic hyperplasia via network pharmacology and molecular dynamics simulation analyses
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the mechanism of action of Qian Lie Xing Fang during the treatment of benign prostatic hyperplasia via network pharmacology and molecular dynamics simulation analyses
Authors
Keywords
-
Journal
MEDICINE
Volume 102, Issue 42, Pages e35540
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-20
DOI
10.1097/md.0000000000035540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of Box-Behnken Design in the Preparation, Optimization, and In-Vivo Pharmacokinetic Evaluation of Oral Tadalafil-Loaded Niosomal Film
- (2023) Kawthar K. Abla et al. Pharmaceutics
- The Physiological and Pathophysiological Role of IL-6/STAT3-Mediated Signal Transduction and STAT3 Binding Partners in Therapeutic Applications
- (2023) Tadashi Matsuda BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Research progress and clinical evaluation of histotripsy: a narrative review
- (2023) Shuaiqi Li et al. Annals of Translational Medicine
- Deciphering anti–benign prostatic hyperplasia potential of liangwanoside II based on metabolite profile characterization combined with targeted network pharmacology
- (2023) Li Fan et al. JOURNAL OF ETHNOPHARMACOLOGY
- The mechanism of Lingze tablets in the treatment of benign prostatic hyperplasia based on network pharmacology and molecular docking technology
- (2022) Chen Shaofeng et al. ANDROLOGIA
- Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
- (2021) Liping Wang et al. Marine Drugs
- IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
- (2021) Junnv Xu et al. Frontiers in Oncology
- Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements
- (2020) Vaishali Aggarwal et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability
- (2020) Anna Mas-Capdevila et al. Nutrients
- The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update
- (2020) Ryan Dornbier et al. Current Urology Reports
- Hesperidin prevents hyperglycemia in diabetic rats by activating the insulin receptor pathway
- (2020) Peng Peng et al. Experimental and Therapeutic Medicine
- Benefits of Hesperidin for Cutaneous Functions
- (2019) Mao-Qiang Man et al. Evidence-based Complementary and Alternative Medicine
- Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
- (2019) Dong-Hyun Youn et al. Frontiers in Pharmacology
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products
- (2015) Milla Kibble et al. NATURAL PRODUCT REPORTS
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now